05:23 PM EDT, 10/03/2025 (MT Newswires) -- Pushkal Garg, Executive Vice President, Chief Research and Development Officer, on October 01, 2025, sold 5,959 shares in Alnylam Pharmaceuticals ( ALNY ) for $2,692,062. Following the Form 4 filing with the SEC, Garg has control over a total of 20,902 common shares of the company, with 20,221 shares held directly and 681 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1178670/000173527625000113/xslF345X05/edgardoc.xml